• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment

Patent holdings for IPC class A61K 47/68

Total number of patents in this class: 12663

10-year publication summary

234
473
831
1002
962
1138
1187
1317
1508
1458
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
SeaGen Inc
594
261
Regeneron Pharmaceuticals, Inc.
4417
211
Daiichi Sankyo Company, Limited
1879
209
Genentech, Inc.
4006
193
MedImmune Limited
627
152
Hanmi Pharm. Co., Ltd.
576
149
Dyne Therapeutics, Inc.
252
138
ImmunoGen, Inc.
403
135
The Regents of the University of California
20245
115
Bristol-myers Squibb Company
4833
95
Novartis AG
10635
92
Bolt Biotherapeutics, Inc.
119
89
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
309
86
Pfizer Inc.
3403
78
Zymeworks Inc.
263
67
ADC Therapeutics SA
123
66
Hoffmann-La Roche Inc.
3523
65
Avidity Biosciences, Inc.
178
65
Memorial Sloan-Kettering Cancer Center
1975
63
Yale University
2436
62
Other owners 10272